Scleroderma: Difference between revisions
3amrbadawy (talk | contribs) (sclero cod) |
Ostermayer (talk | contribs) (Text replacement - "Category:Rheum" to "Category:Rheumatology") |
||
| Line 43: | Line 43: | ||
<references/> | <references/> | ||
[[Category: | [[Category:Rheumatology]] | ||
Revision as of 16:17, 22 March 2016
Background
- Autoimmune disease, aka Systemic Sclerosis
- Inappropriate and excessive accumulation of collagen and matrix in various tissues
- Widespread vascular lesions
- Endothelial dysfunction
- Vascular spasm
- Vascular wall thickening
- Narrowed lumen
Clinical Features
- Systemic complaints (fever, malaise, fatigue, weight loss, myalgias)
- Skin lesions (fingers, hands, face)
- Carpal tunnel
- Raynaud's
- Interstitial lung disease
- Renal impairment
- GI dysmotility
- GERD/aspiration
- Chronic esophagitis and stricture formation
Emergencies
- Scleroderma renal crisis
- Causes HTN emergency
- Treatment is strict BP control - ACEi drug of choice
- Was the most common cause of death prior to ACEi usage[1]
- Pulmonary
- Respiratory failure
- ARDS
- Aspiration pneumonitis
- Pulmonary HTN
- Alveolar hemorrhage
- Hemoptysis, infiltrates on CXR, anemia.
- Emergent bronchoscopy
- High dose glucocorticoids, cyclophosphamide, local vessel embolization or plasma exchange
- Cardiac
References
- Tintinalli
- ↑ Komocsi A, Vorobcsuk A, Faludi R, et al. The impact of cardiopulmonary manifestations on the mortality of SSc: a systematic review and meta-analysis of observational studies. Rheumatology (Oxford) 2012;51:1027–1036
- ↑ Nikpour, M., Baron, M. Mortality in systemic sclerosis: lessons learned from population-based and observational cohort studies. Curr Opin Rheumatol. 2014;26:131–137
- ↑ Komocsi A, Vorobcsuk A, Faludi R, et al. The impact of cardiopulmonary manifestations on the mortality of SSc: a systematic review and meta-analysis of observational studies. Rheumatology (Oxford) 2012;51:1027–1036
- ↑ Tyndall AJ, Bannert B, Vonk M, Airo P, Cozzi F, Carreira PE, et al. Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database. Ann Rheum Dis. 2010;69:1809–15. doi: 10.1136/ard.2009.114264
